Adc Therapeutics SA Overview

Adc Therapeutics SA EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ADCT.

Quarterly EBIT

-$25.25M

↑ 11.31% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$107.14M

↑ 5.38% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin